Skip to main content
. 2022 Jan 28;28(4):464–478. doi: 10.3748/wjg.v28.i4.464

Figure 1.

Figure 1

Expression and prognostic value of DEAD-box helicase 51 in esophageal cancer. A: Immunohistochemistry analysis of DEAD-box helicase 51 (DDX51) expression in tumor tissues and paired normal tissues of patients with esophageal squamous cell carcinoma (ESCC); B: Quantitative PCR detection of DDX51 mRNA expression in the tumor tissues (n = 118) and paired normal tissues (n = 118) of patients with ESCC, aP < 0.05; C: Survival curves of ESCC patients with high or low expression (P = 0.0036).